Literature DB >> 23365103

SGCE mutations cause psychiatric disorders: clinical and genetic characterization.

Kathryn J Peall1, Daniel J Smith, Manju A Kurian, Mark Wardle, Adrian J Waite, Tammy Hedderly, Jean-Pierre Lin, Martin Smith, Alan Whone, Hardev Pall, Cathy White, Andrew Lux, Philip Jardine, Narinder Bajaj, Bryan Lynch, George Kirov, Sean O'Riordan, Michael Samuel, Timothy Lynch, Mary D King, Patrick F Chinnery, Thomas T Warner, Derek J Blake, Michael J Owen, Huw R Morris.   

Abstract

Myoclonus dystonia syndrome is a childhood onset hyperkinetic movement disorder characterized by predominant alcohol responsive upper body myoclonus and dystonia. A proportion of cases are due to mutations in the maternally imprinted SGCE gene. Previous studies have suggested that patients with SGCE mutations may have an increased rate of psychiatric disorders. We established a cohort of patients with myoclonus dystonia syndrome and SGCE mutations to determine the extent to which psychiatric disorders form part of the disease phenotype. In all, 89 patients with clinically suspected myoclonus dystonia syndrome were recruited from the UK and Ireland. SGCE was analysed using direct sequencing and for copy number variants. In those patients where no mutation was found TOR1A (GAG deletion), GCH1, THAP1 and NKX2-1 were also sequenced. SGCE mutation positive cases were systematically assessed using standardized psychiatric interviews and questionnaires and compared with a disability-matched control group of patients with alcohol responsive tremor. Nineteen (21%) probands had a SGCE mutation, five of which were novel. Recruitment of family members increased the affected SGCE mutation positive group to 27 of whom 21 (77%) had psychiatric symptoms. Obsessive-compulsive disorder was eight times more likely (P < 0.001) in mutation positive cases, compulsivity being the predominant feature (P < 0.001). Generalized anxiety disorder (P = 0.003) and alcohol dependence (P = 0.02) were five times more likely in mutation positive cases than tremor controls. SGCE mutations are associated with a specific psychiatric phenotype consisting of compulsivity, anxiety and alcoholism in addition to the characteristic motor phenotype. SGCE mutations are likely to have a pleiotropic effect in causing both motor and specific psychiatric symptoms.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23365103      PMCID: PMC4052887          DOI: 10.1093/brain/aws308

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  69 in total

Review 1.  Functional MRI and the study of OCD: from symptom provocation to cognitive-behavioral probes of cortico-striatal systems and the amygdala.

Authors:  H C Breiter; S L Rauch
Journal:  Neuroimage       Date:  1996-12       Impact factor: 6.556

2.  The epsilon-sarcoglycan gene in myoclonic syndromes.

Authors:  E M Valente; M J Edwards; P Mir; A DiGiorgio; S Salvi; M Davis; N Russo; M Bozi; H-T Kim; G Pennisi; N Quinn; B Dallapiccola; K P Bhatia
Journal:  Neurology       Date:  2005-02-22       Impact factor: 9.910

3.  Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II.

Authors:  J B Saunders; O G Aasland; T F Babor; J R de la Fuente; M Grant
Journal:  Addiction       Date:  1993-06       Impact factor: 6.526

4.  Phenotype-genotype correlation in Dutch patients with myoclonus-dystonia.

Authors:  M C F Gerrits; E M J Foncke; R de Haan; K Hedrich; Y L C van de Leemput; F Baas; L J Ozelius; J D Speelman; C Klein; M A J Tijssen
Journal:  Neurology       Date:  2006-03-14       Impact factor: 9.910

5.  Analysis of the epsilon-sarcoglycan gene in familial and sporadic myoclonus-dystonia: evidence for genetic heterogeneity.

Authors:  Enza-Maria Valente; Anjum Misbahuddin; Francesco Brancati; Mark R Placzek; Barbara Garavaglia; Sergio Salvi; Andrea Nemeth; Charles Shaw-Smith; Nardo Nardocci; Anna-Rita Bentivoglio; Alfredo Berardelli; Roberto Eleopra; Bruno Dallapiccola; Thomas T Warner
Journal:  Mov Disord       Date:  2003-09       Impact factor: 10.338

6.  "Jerky" dystonia in children: spectrum of phenotypes and genetic testing.

Authors:  Friedrich Asmus; Annette Langseth; Elaine Doherty; Therese Nestor; Marita Munz; Thomas Gasser; Tim Lynch; Mary D King
Journal:  Mov Disord       Date:  2009-04-15       Impact factor: 10.338

7.  Phenotypic features of myoclonus-dystonia in three kindreds.

Authors:  D O Doheny; M F Brin; C E Morrison; C J Smith; R H Walker; S Abbasi; B Müller; J Garrels; L Liu; P De Carvalho Aguiar; K Schilling; P Kramer; D De Leon; D Raymond; R Saunders-Pullman; C Klein; S B Bressman; B Schmand; M A J Tijssen; L J Ozelius; J M Silverman
Journal:  Neurology       Date:  2002-10-22       Impact factor: 9.910

8.  Primary focal dystonia: evidence for distinct neuropsychiatric and personality profiles.

Authors:  R Lencer; S Steinlechner; J Stahlberg; H Rehling; M Orth; T Baeumer; H-J Rumpf; C Meyer; C Klein; A Muenchau; J Hagenah
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-05-21       Impact factor: 10.154

9.  Validity and reliability of a rating scale for the primary torsion dystonias.

Authors:  R E Burke; S Fahn; C D Marsden; S B Bressman; C Moskowitz; J Friedman
Journal:  Neurology       Date:  1985-01       Impact factor: 9.910

10.  Psychiatric disorders in adult-onset focal dystonia: a case-control study.

Authors:  Giovanni Fabbrini; Isabella Berardelli; Germana Moretti; Massimo Pasquini; Maria Bloise; Carlo Colosimo; Massimo Biondi; Alfredo Berardelli
Journal:  Mov Disord       Date:  2010-03-15       Impact factor: 10.338

View more
  30 in total

1.  Associations of specific psychiatric disorders with isolated focal dystonia, and monogenic and idiopathic Parkinson's disease.

Authors:  Susanne Steinlechner; Johann Hagenah; Hans-Jürgen Rumpf; Christian Meyer; Ulrich John; Tobias Bäumer; Norbert Brüggemann; Meike Kasten; Alexander Münchau; Christine Klein; Rebekka Lencer
Journal:  J Neurol       Date:  2017-04-11       Impact factor: 4.849

2.  Long-term neuropsychiatric outcomes after pallidal stimulation in primary and secondary dystonia.

Authors:  Sara Meoni; Mateusz Zurowski; Andres M Lozano; Mojgan Hodaie; Yu-Yan Poon; Melanie Fallis; Valerie Voon; Elena Moro
Journal:  Neurology       Date:  2015-07-08       Impact factor: 9.910

Review 3.  Genetic studies of alcohol dependence in the context of the addiction cycle.

Authors:  Matthew T Reilly; Antonio Noronha; David Goldman; George F Koob
Journal:  Neuropharmacology       Date:  2017-01-22       Impact factor: 5.250

4.  Treatment of myoclonus-dystonia syndrome with tetrabenazine.

Authors:  Angelo Y Luciano; H A Jinnah; Ronald F Pfeiffer; Daniel D Truong; Martha A Nance; Mark S LeDoux
Journal:  Parkinsonism Relat Disord       Date:  2014-10-05       Impact factor: 4.891

5.  Myoclonus-dystonia and epilepsy in a family with a novel epsilon-sarcoglycan mutation.

Authors:  Kristoffer Haugarvoll; Charalampos Tzoulis; Gia T Tran; Bjørn Karlsen; Bernt A Engelsen; Per M Knappskog; Laurence A Bindoff
Journal:  J Neurol       Date:  2013-12-03       Impact factor: 4.849

6.  Prominent Lower-Limb Involvement in a Family with Myoclonus-Dystonia.

Authors:  Christopher Kobylecki; Dinesh Damodaran; Bronwyn Kerr; Richard W Newton; Monty A Silverdale
Journal:  Mov Disord Clin Pract       Date:  2014-05-26

7.  A Novel SGCE Nonsense Variant Associated With Marked Intrafamilial Variability in a Turkish Family With Myoclonus-Dystonia.

Authors:  Murat Gultekin; Neha Prakash; Christos Ganos; Meral Mirza; Ruslan Bayramov; Kailash P Bhatia; Niccolò E Mencacci
Journal:  Mov Disord Clin Pract       Date:  2019-07-17

Review 8.  Nosology and Phenomenology of Psychosis in Movement Disorders.

Authors:  Malco Rossi; Nicole Farcy; Sergio E Starkstein; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2020-01-07

9.  Low CSF 5-HIAA in Myoclonus Dystonia.

Authors:  Kathryn J Peall; Joanne Ng; Marisela E Dy; Nutan Sharma; Simon Pope; Simon Heales; Jennifer R Friedman; Manju A Kurian
Journal:  Mov Disord       Date:  2017-09-26       Impact factor: 10.338

10.  Role of major and brain-specific Sgce isoforms in the pathogenesis of myoclonus-dystonia syndrome.

Authors:  Jianfeng Xiao; Satya R Vemula; Yi Xue; Mohammad M Khan; Francesca A Carlisle; Adrian J Waite; Derek J Blake; Ioannis Dragatsis; Yu Zhao; Mark S LeDoux
Journal:  Neurobiol Dis       Date:  2016-11-24       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.